Gwyn Williams

Boston
  • 200 Clarendon Street
  • Boston, MA 02116
  • USA
 
 

Gwyn Williams, a partner and Global Chair of the Product Liability, Mass Torts & Consumer Class Actions Practice, has extensive experience in the defense of mass tort and product liability claims, and other types of personal injury/wrongful death claims. Her experience has encompassed the defense of manufacturers of cigarettes, industrial products, and a wide range of pharmaceutical products and medical devices.

Ms. Williams’ consumer class action experience includes cases involving a variety of consumer products, work in the consumer financial services sector and experience with a wide variety of state and federal consumer protection statutes. She provides products liability counseling to clients on matters such as the content and dissemination of product warnings, disclaimers of warranties and indemnification strategies. She has also performed products liability risk assessment (including assessments of the magnitude of potential asbestos liability) for private equity firms, operating companies considering acquisitions and pension fund investment advisers.

Ms. Williams also has considerable experience in energy-related litigation, including the defense of governmental and citizen-suit enforcement actions under the major federal environmental acts, as well as their New York, Massachusetts and Vermont counterparts.

Ms. Williams has practiced before state and federal trial and appellate courts and administrative agencies across the United States and is admitted to practice before the District of Massachusetts and the US Court of Appeals for the D.C., First, Second, Fifth and Ninth Circuits. She is a frequent speaker on issues relating to mass torts and consumer class actions, and she is a contributing author for the 50 State Survey of Consumer Class Action Law, published by the American Bar Association.

  • Served as trial and coordinating counsel for Teva Pharmaceuticals in significant product liability and consumer class action litigation involving the drug propofol* 
  • Represented a major pharmacy chain as national mass tort counsel, defending the issue of pharmacy liability for allegedly defective drugs such as “fen-phen,” OxyContin and hormone replacement therapy. These cases involved class actions and a variety of products liability issues in state and federal jurisdictions around the country, including in federal multidistrict litigation (MDL)*
  • Tobacco litigation defense on behalf of Philip Morris International and Philip Morris USA, including consumer class actions and aggregated smoking and health claims brought by union health funds and governmental entities*
  • Served as national counsel for a manufacturing defendant in the welding rod products liability litigation; represented the company in more than 400 federal and state court cases filed in Alabama, Arkansas, Georgia, Illinois, Louisiana, Mississippi, Ohio, Texas, Utah and West Virginia* 
    • Appointed by the court to serve as liaison counsel, in the consolidated federal MDL, for a group of manufacturing defendants* 
  • Litigation arising out of nuclear operations by the huge energy concern, Entergy Nuclear, Inc., including: (i) the strategic defense of Entergy’s nuclear facilities facing scrutiny of their cooling water intake structures under §316(b) of the Clean Water Act and other statutes; (ii) challenges to federal and state rule-making affecting Entergy; and (iii) litigating on Entergy’s behalf in state courts and administrative tribunals, concerning Entergy’s nuclear power production facilities and the release of cooling water* 
    • Argued to the highest courts in Massachusetts and Vermont on behalf of Entergy*

*Matters handled prior to joining the firm

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.